Richard L. Hurwitz

3.4k total citations · 1 hit paper
64 papers, 2.6k citations indexed

About

Richard L. Hurwitz is a scholar working on Molecular Biology, Ophthalmology and Genetics. According to data from OpenAlex, Richard L. Hurwitz has authored 64 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Ophthalmology and 13 papers in Genetics. Recurrent topics in Richard L. Hurwitz's work include Ocular Oncology and Treatments (14 papers), Virus-based gene therapy research (13 papers) and Retinal Development and Disorders (12 papers). Richard L. Hurwitz is often cited by papers focused on Ocular Oncology and Treatments (14 papers), Virus-based gene therapy research (13 papers) and Retinal Development and Disorders (12 papers). Richard L. Hurwitz collaborates with scholars based in United States, France and Finland. Richard L. Hurwitz's co-authors include Patricia Chévez‐Barrios, Mary Y. Hurwitz, Murali Chintagumpala, Joseph A. Beavo, Tucker W. LeBien, V Holcombe, Evelyn A. Paysse, Mark A. Rayfield, Lois Conley and Kenneth G. Castro and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Richard L. Hurwitz

64 papers receiving 2.4k citations

Hit Papers

Transmission of Human Immunodeficiency Virus Type 1 from ... 1992 2026 2003 2014 1992 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard L. Hurwitz United States 26 1.1k 462 432 399 366 64 2.6k
Hiroshi Takahashi Japan 29 951 0.8× 681 1.5× 391 0.9× 200 0.5× 259 0.7× 158 2.7k
Masaki Takeuchi Japan 35 1.4k 1.2× 480 1.0× 854 2.0× 242 0.6× 304 0.8× 181 4.0k
Steven R. Cohen United States 33 812 0.7× 83 0.2× 683 1.6× 609 1.5× 223 0.6× 128 3.6k
Trevor Gray United Kingdom 26 520 0.5× 679 1.5× 206 0.5× 180 0.5× 139 0.4× 48 2.4k
Leona Cohen‐Gould United States 27 1.5k 1.3× 71 0.2× 332 0.8× 200 0.5× 269 0.7× 43 2.9k
G Gabbiani Switzerland 25 955 0.8× 111 0.2× 576 1.3× 152 0.4× 259 0.7× 63 2.8k
Stephen R. Planck United States 38 1.5k 1.3× 1.2k 2.5× 166 0.4× 187 0.5× 303 0.8× 110 4.0k
Ben-Zion Levi Israel 32 2.3k 2.1× 177 0.4× 180 0.4× 409 1.0× 1.1k 3.0× 56 4.2k
Jun Cheng China 29 2.0k 1.8× 188 0.4× 286 0.7× 329 0.8× 362 1.0× 110 4.4k
Brad A. Amendt United States 37 3.6k 3.2× 107 0.2× 242 0.6× 783 2.0× 267 0.7× 116 4.7k

Countries citing papers authored by Richard L. Hurwitz

Since Specialization
Citations

This map shows the geographic impact of Richard L. Hurwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard L. Hurwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard L. Hurwitz more than expected).

Fields of papers citing papers by Richard L. Hurwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard L. Hurwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard L. Hurwitz. The network helps show where Richard L. Hurwitz may publish in the future.

Co-authorship network of co-authors of Richard L. Hurwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Richard L. Hurwitz. A scholar is included among the top collaborators of Richard L. Hurwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard L. Hurwitz. Richard L. Hurwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ildefonso, Cristhian J., et al.. (2020). Inhibitors of metalloprotease, γ-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication. PLoS ONE. 15(7). e0236175–e0236175. 1 indexed citations
2.
3.
Wadhwa, Lalita, László Perlaky, Rebecca L. Penland, et al.. (2011). Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice. Journal of Visualized Experiments. 3 indexed citations
4.
Wadhwa, Lalita, László Perlaky, Rebecca L. Penland, et al.. (2011). Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice. Journal of Visualized Experiments. 6 indexed citations
5.
Ildefonso, Cristhian J., Lingkun Kong, Ann M. Leen, et al.. (2010). Absence of Systemic Immune Response to Adenovectors After Intraocular Administration to Children With Retinoblastoma. Molecular Therapy. 18(10). 1885–1890. 14 indexed citations
6.
Wadhwa, Lalita, Mary Y. Hurwitz, Patricia Chévez‐Barrios, & Richard L. Hurwitz. (2007). Treatment of Invasive Retinoblastoma in a Murine Model Using an Oncolytic Picornavirus. Cancer Research. 67(22). 10653–10656. 44 indexed citations
7.
Chintagumpala, Murali, Patricia Chévez‐Barrios, Evelyn A. Paysse, Sharon E. Plon, & Richard L. Hurwitz. (2007). Retinoblastoma: Review of Current Management. The Oncologist. 12(10). 1237–1246. 148 indexed citations
8.
Chaudhuri, Saumya Ray, Patricia Chévez‐Barrios, Lalita Wadhwa, et al.. (2006). Modulation of Adenoviral Transduction In Vitro and In Vivo by Hyaluronan and its Receptor CD44. Molecular Therapy. 15(3). 566–570. 9 indexed citations
9.
Chong, Eva-Marie, Robert E. Coffee, Murali Chintagumpala, et al.. (2006). Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.. PubMed. 130(11). 1669–72. 25 indexed citations
10.
Chévez‐Barrios, Patricia, Ann M. Leen, Murali Chintagumpala, et al.. (2005). Immune Response of Retinoblastoma Treated With Suicide Gene Therapy Using Adenoviral–Mediated Delivery of Thymidine Kinase Followed by Ganciclovir. Investigative Ophthalmology & Visual Science. 46(13). 5218–5218. 1 indexed citations
11.
Chévez‐Barrios, Patricia, Murali Chintagumpala, William F. Mieler, et al.. (2005). Response of Retinoblastoma With Vitreous Tumor Seeding to Adenovirus-Mediated Delivery of Thymidine Kinase Followed by Ganciclovir. Journal of Clinical Oncology. 23(31). 7927–7935. 101 indexed citations
12.
Hurwitz, Richard L., et al.. (2003). Matrix Metalloproteinases in Retinoblastoma: Correlation with Metastatic Behavior. Investigative Ophthalmology & Visual Science. 44(13). 1421–1421. 4 indexed citations
13.
Hurwitz, Richard L., Patricia Chévez‐Barrios, Milton Boniuk, Murali Chintagumpala, & Mary Y. Hurwitz. (2003). Retinoblastoma: from bench to bedside. Expert Reviews in Molecular Medicine. 5(1). 1–22. 8 indexed citations
15.
Paulín, Lars, et al.. (1997). Cloning of the cDNA encoding rod photoreceptor cGMP-phosphodiesterase α and γ subunits from the retinal degenerate Labrador Retriever dog. Research in Veterinary Science. 62(3). 293–296. 4 indexed citations
16.
Srivastava, Devesh, Richard L. Hurwitz, & Donald A. Fox. (1995). Lead- and Calcium-Mediated Inhibition of Bovine Rod cGMP Phosphodiesterase: Interactions with Magnesium. Toxicology and Applied Pharmacology. 134(1). 43–52. 11 indexed citations
17.
Mahoney, Donald H., et al.. (1992). Soft‐tissue sarcomas other than rhabdomyosarcoma in children. Medical and Pediatric Oncology. 20(2). 114–118. 18 indexed citations
18.
Hurwitz, Richard L., et al.. (1985). Phosphodiesterase-probes show distinct defects in rd mice and Irish setter dog disorders.. PubMed. 26(11). 1569–79. 15 indexed citations
19.
Smith, Stanley B., et al.. (1981). Experience with Subclavian Vein for Vascular Access. PubMed. 5(3). 293–297. 2 indexed citations
20.
Kersey, JH, Tucker W. LeBien, Richard L. Hurwitz, et al.. (1979). Childhood leukemia-lymphoma. Heterogeneity of phenotypes and prognoses.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(4 Suppl). 746–52. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026